Prediction: IonQ Price Target Surges with 383% Upside
IonQ delivers a standout Q1 and a fresh price-target outlook that signals potential triple-digit gains over the next ...
Thinking of using a balance transfer card? Here are key considerations to help you make informed decisions and manage your debt.
23,841 articlesIonQ delivers a standout Q1 and a fresh price-target outlook that signals potential triple-digit gains over the next ...
Coinbase expands its collateral options by adding SOL to its crypto-backed loan program, unlocking new borrowing powe...
Google’s Gemini AI released a bold Solana forecast, pairing a performance upgrade roadmap with a price trajectory tha...
CVS Health recently touched a fresh 52-week high after strong Q1 results. This deep dive explains why the rally may c...
Oil prices push higher as supply fears mount, triggering a broad debt selloff and jittery stock futures. Iran tension...
The S&P 500 now carries an 18% semiconductor exposure, a level unseen since the dot-com era. A handful of chipmakers ...
In 2026, XLK’s cap-driven approach has quietly outpaced FTEC. Concentration limits are redirecting capital toward sem...
Pagaya Technologies posted stronger-than-expected Q1 results, raised full-year guidance, and trades below $14, presen...
A new advocacy group backing Kalshi’s prediction market efforts has publicly launched in Washington, with former Whit...
Public tours of Jim Henson's Creature Shop in Queens reveal the hidden craft behind Kermit and friends. The 80-minute...
Ethereum’s bounce prospects hinge on institutional access and policy clarity. A new staking ETF and rising regulatory...
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...